Teardown

Insurance · Deep dive

Aflac Incorporated

Supplemental cancer, accident and hospital insurance paid in cash to policyholders — with 55% of revenue earned in Japan.

well positioned

A 70-year-old Japanese cancer-insurance franchise bolted to a disciplined US worksite distribution motor, insulated by Japan Post's 7% stake and the duck.

My take

Founded
1955
Headcount
12694
Screen
Published
2026-11-05
Web
www.aflac.com
Elsewhere
LinkedIn · Crunchbase

Founders and leadership

  • John Amos Co-founder, first CEO 1955-1990

  • Paul Amos Co-founder

  • William 'Bill' Amos Co-founder

Snapshot

Aflac is the duck-ad company that is really a Japanese cancer-insurance franchise with a US worksite distribution motor bolted on. Founded in 1955 in Columbus, Georgia by brothers John, Paul and William Amos — and run today by their nephew Dan Amos, who has been chairman and CEO since 1990 — Aflac sells supplemental insurance that pays cash directly to policyholders to cover deductibles, lost wages and non-medical expenses after a covered event. US revenue comes through brokers and payroll-deduction enrollment at employers; Japan revenue — the bigger half — comes through 6,600 sales agencies, 114,000 licensed associates, 37,000 Dai-ichi Life reps, 360 Japanese banks and more than 20,000 Japan Post postal outlets. Market cap sat at $57.8B at year-end 2025 and $58.3B on September 15, 2026, per StockAnalysis. Japan Post Holdings owns roughly 7% of the parent, a 2018 strategic investment that doubled as a distribution deal. The float is $109.5B as of Q3 2025. The dividend has risen for 43 consecutive years.

Founding story

November 17, 1955: Three Amos brothers in Columbus, Georgia — John, Paul and William — incorporate American Family Life Insurance Company of Columbus. The initial product line is unremarkable general life insurance. 1958: Aflac shifts to selling cancer insurance, a product Americans at the time largely couldn't buy — cancer treatment was out-of-pocket for most households. 1964: The company renames to American Family Life Assurance Company and moves decisively to worksite payroll-deduction. 1974: Aflac goes public on the NYSE and enters Japan the same year — the single most consequential decision in the company's history. 1990: Dan Amos (nephew of the founders) becomes CEO; the three founder brothers hand the reins to the next generation. 1990: The company formally adopts "Aflac" as its corporate name. Paul Amos died in July 2014; John and Bill predeceased him. Dan Amos remains chairman and CEO today, the longest-tenured insurance chief executive in America.

How it works

Supplemental insurance pays cash directly to the policyholder when a covered event occurs — unlike health insurance, which pays the provider. Aflac's claims-pay-fast pitch is its most durable differentiator; the One Day Pay platform launched February 2015 processes qualifying claims within one business day. Core US products: accident, cancer/critical illness, hospital indemnity, short-term disability, dental and vision, and (via the 2020 Zurich North America corporate-benefits acquisition) group life and disability. Aflac Japan is primarily a cancer and medical third-sector specialist, where Japan's single-payer healthcare covers most direct cost but patients still face non-covered expenses, income loss and long-term care.

Distribution is where the economics live. In the US, Aflac enrolls at the worksite via independent contract agents who are paid on 100% commission. In Japan, Aflac has institutionalized access: 6,600 agencies, 114,000 licensed associates, Dai-ichi Life's 37,000 reps under a long-standing alliance, 360 banks (90% of Japanese banks), more than 20,000 Japan Post postal outlets, and Japan Post Insurance offices. This matters because Japanese household penetration of cancer insurance is near-universal, and the distribution incumbents — not the product — are the moat.

Product and business overview

Two reportable segments: Aflac Japan (55% of 2024 adjusted revenues, 77% of consolidated assets) and Aflac US. Japan earns ~70% of pretax adjusted earnings per Brand Hopper's February 2026 competitor profile. US adjacencies added via acquisition: Zurich North America's group benefits (closed late 2020), expanding corporate-market dental, life and disability, and a 9% stake in Trupanion (October 2020) with a US pet-insurance distribution alliance, plus the Aflac Pet Insurance joint venture launched in Japan November 2022.

Business model and pricing

Premiums collected monthly, often via payroll deduction. Claims paid as cash lump sums, typically fast. Published starting monthly premiums for a 20-year-old Nebraska non-smoker (per ThePricer compilation of Aflac quotes): accident $24.91, cancer $20.41, dental $26.05. Worksite accident coverage runs as low as $3.51–$6.50 per month for employee-only coverage in public-sector negotiated deals. 2024 total benefits and claims ran roughly $8.1B on $18.9B revenue; Q3 2025 benefit ratio implied ~62% of policy premiums — a disciplined level that leaves room for the 43-year dividend-raise streak.

Traction over time

Revenue trajectory: 2023 ~$18.7B, 2024 $18.9B (+1.2% YoY), YTD-9M 2025 $12.3B. Net earnings: 2024 $5.44B (+17%, per Simply Wall St on the 10-K). Q3 2025 net income $1.6B ($3.08 diluted EPS). Employees at year-end 2024: 12,694 full-time (Japan 6,737, US 5,041, Corporate 916). Aflac Japan carries more than 22 million in-force policies; Aflac US has approximately 50 million active cards and policies across subsidiaries historically. Investment portfolio $109.5B at September 30, 2025. The dividend was raised for the 43rd consecutive year in Q3 2025.

Market analysis

US supplemental health insurance: Milliman's fourth annual State-of-the-Supplemental-Market Survey (January 2024) covered 54 carriers across 17 products; Allied Market Research pegs the US supplemental health market at ~$46B in 2023, projected to top $80B by 2032 at mid-single-digit CAGR. Japan cancer insurance: approximately 22 million individual cancer policies in force as of FY2022 per Statista; the IMARC Group projects Japan's total private health insurance market at ~$296B by 2033. Cancer insurance specifically is a third-sector sub-segment deregulated in 2001. Structural forces: (1) aging population in Japan drives persistency and medical-rider attach; (2) US worksite demand up as employers reshape benefits post-ACA and inflation; (3) direct-to-consumer insurtech sucks the lower-acuity portion of the US market.

Competitive intel

US voluntary: Unum / Colonial Life is the closest mirror of Aflac's US model, dominant in K-12 schools and public-sector groups. Allstate Benefits (American Heritage Life) is a top-5 supplemental carrier that leverages Allstate's agent force. MetLife bundles supplemental with dental, vision and life — the most formidable global rival. Lincoln Financial, Guardian and Prudential compete across voluntary slices. Cigna bundles supplemental with medical. Aflac holds about 27% of the US worksite supplemental market per Brand Hopper (February 2026).

Japan: Dai-ichi Life, Nippon Life, Sony Life, Japan Post Insurance, Tokio Marine, MS&AD, plus MetLife Japan and Prudential of Japan. Aflac Japan's historical cancer monopoly eroded from approximately 99% share in 1991 (Nikkei) to roughly 50% today after Japan's 2001 third-sector deregulation (Quartz, October 16, 2013). Japan Post Holdings' 7% stake in Aflac Inc. (~$2.6B, December 2018, equity-method accounting) came with deeper postal-outlet distribution and is a durable strategic anchor — the kind of equity-plus-distribution tie that is very hard for rivals to replicate.

History and evolution

1955: Founded. 1958: First cancer policy in US. 1964: Worksite-payroll pivot. 1974: NYSE IPO + Japan market entry. 1990: Dan Amos becomes CEO; Aflac acronym adopted. December 1999: The Aflac duck ad campaign launches (Kaplan Thaler Group); the duck becomes one of the most recognized mascots in US advertising. 2008: Financial crisis hits investment portfolio on European hybrid and bank-perpetual bond holdings (per 2008 10-K). February 2015: One Day Pay launches. January 2018: The Intercept (David Dayen) publishes a multi-part investigation on the 100% commission structure, independent-contractor misclassification claims and bundled sales practices; Aflac denied and compelled arbitration. Mid-2018: settled with five state AGs for $350,000 total. December 2018: Japan Post Holdings acquires 7% of Aflac Inc. ($2.6B). March 2020: Aflac agrees to acquire Zurich North America's US corporate benefits business (closed late 2020). October 2020: Aflac takes a 9% stake in Trupanion with a US distribution alliance. November 2022: Aflac Pet Insurance JV launched in Japan with Trupanion. June 2025: A cybersecurity incident is detected on limited systems; later confirmed to affect approximately 22.65 million individuals (names, SSNs, health and claims data) per Security Affairs (December 26, 2025). Not ransomware; press tied it to the Scattered Spider wave.

What people say

The case for. Fortune has listed Aflac among the World's Most Admired Companies for more than 15 consecutive years. Brand recall is extraordinary — the duck is a top-tier US mascot alongside the GEICO Gecko and the Energizer Bunny. One Day Pay regularly draws praise for actually delivering on its SLA. S&P A+ and AM Best A+ ratings reflect disciplined underwriting. Policy pricing at the worksite is typically praised relative to retail alternatives. The 43-year dividend-raise streak is one of the longest in the S&P 500.

The complaints. BBB and Trustpilot reviews cluster around denied claims, slow larger-payout cycles, surprise premium increases and difficulty cancelling. Glassdoor themes for Aflac sales reps are remarkably consistent: 100% commission compensation, high churn (average tenure reportedly under one year per the 2018 draft complaint cited by The Intercept), under-2% of new agents reaching advertised income examples (the $125K first-year projection), and heavy self-funded overhead ($300–$600/month office rent). The Intercept series in January 2018 and parallel lawsuits alleged independent-contractor misclassification and policy-bundling without consent. Analyst coverage (Morningstar, Barclays, Evercore) typically rates AFL Hold or Underperform on slow Japan top-line and US benefit-ratio pressure, while praising capital return. The 22.65-million-individual breach disclosed in mid-2025 is the most significant operational event of Dan Amos's tenure and remains an unresolved liability.

Outlook: well positioned or at risk?

Well-positioned. The structural reasons Aflac compounds are not glamorous but they are durable. Japan Post's 7% equity stake is a near-permanent distribution lock on the Japanese cancer market. The US worksite commission-based motor, however problematic for the agents inside it, is cheap to run from a carrier perspective: Aflac does not pay salaries while agents search for prospects. One Day Pay is a product-market-fit differentiator that is unusually hard to copy because it requires both digital infrastructure and reserving discipline. The 43-year dividend streak enforces operational conservatism. Benefit ratios stay in the low 60s, which leaves genuine margin for both reserving and buybacks. The cyber incident is a real liability but not a franchise-breaker in a category where competitors (Prudential, Lincoln) have also had recent breaches. Japan's cancer-insurance incumbency since 1974 is 50+ years of compounding distribution relationships that are very difficult to displace.

How to attack it

The exposed wedge is employer-direct, salaried-enrollment supplemental. Aflac's independent-agent-on-100%-commission model creates a loud, persistent complaint channel that an insurtech with a very different distribution model can exploit. BestMoney, Nayya, Benepass, Thatch, and TrueAccord all have pieces of this but none has yet built a full-stack supplemental carrier with direct-to-employer enrollment, no commissioned agent force, and a digital claims experience that beats One Day Pay. A Series A team that partnered with a fronting carrier (Clear Blue, Accelerant, Trisura) could underwrite supplemental products with 50–70% lower acquisition costs than Aflac and pass that back as either premium or benefit.

Aflac's exposed flanks: (1) Agent-model reputational drag — The Intercept series, Glassdoor, and recurring state AG settlements are all live liabilities a direct-to-employer pitch can weaponize; (2) Non-Japan growth — US growth is under 2%; Aflac has struggled in international expansion beyond Japan; (3) Breach exposure — the 22.65M-individual 2025 cyber incident creates both a trust gap and an opportunity for cyber-native underwriters; (4) Analog claims adjudication — One Day Pay is fast for simple claims but complex claims still move slowly, and the cash-payout model is awkward with HSA/FSA reform; (5) Pet insurance — the Trupanion partnership has yet to scale; a direct pet-insurance attacker can displace it. A seed team should pick exactly one of these — likely (1) — and build.

Adjacent-segment play

The strongest adjacent is embedded supplemental insurance. Aflac's core product — cash on a covered event — is the natural pairing for consumer-facing financial products: a cancer rider embedded in life insurance, a hospital-indemnity rider embedded in HSA accounts, an accident rider embedded in travel bookings or gym memberships. The infrastructure exists (Cover Genius, Boost Insurance, Qover). The wedge is to build a carrier-grade supplemental product that a Shopify-style embed partner can wire into an existing commerce flow. Aflac can't be this because its cost structure is built around the agent commission. A new entrant can.

A second adjacent: direct-to-worker supplemental for the 1099 workforce. Uber drivers, DoorDash shoppers and gig workers broadly have essentially no worksite enrollment channel. The 60 million US gig workers represent an under-penetrated supplemental market Aflac's distribution cannot reach. A third adjacent: supplemental for Southeast Asia and Latin America — markets where private medical is thin, public coverage is incomplete and the cultural franchise Aflac built in Japan is replicable with a 50-year lead time removed. A fourth: critical-illness products for the mid-market US employer where MetLife and Unum compete but no specialist has crisper product design.

Sources and further reading

Competitive set

  • Unum (Colonial Life) —
  • Allstate Benefits (American Heritage Life) —
  • MetLife —
  • Lincoln Financial —
  • Guardian Life —
  • Prudential Financial —
  • Cigna —
  • Japanese rivals (Dai-ichi, Nippon Life, Sony Life, Japan Post Insurance, Tokio Marine) —